Published • loading... • Updated
Is Access to Treatment at Risk? Europe Addresses the Consequences of US Pressure on Drug Prices
Summary by cedarnews.net
Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.1 Articles
1 Articles
نُشر هذا مقاعد ولاً عبر Cedarnews.net. To follow more of the news and reports, click on our website. In the 10 months since the start of the MFN programme, the number of new drug launches across Europe has fallen by 35%. MEPs therefore call on member states to. تم نشر هذا الخبر عبر صوت كيدرنوس الخباري. To see more of the latest news, click on our official website.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
